Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27807
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMangiola, Stefano-
dc.contributor.authorMcCoy, Patrick-
dc.contributor.authorModrak, Martin-
dc.contributor.authorSouza-Fonseca-Guimaraes, Fernando-
dc.contributor.authorBlashki, Daniel-
dc.contributor.authorStuchbery, Ryan-
dc.contributor.authorKeam, Simon P-
dc.contributor.authorKerger, Michael-
dc.contributor.authorChow, Ken-
dc.contributor.authorNasa, Chayanica-
dc.contributor.authorLe Page, Melanie-
dc.contributor.authorLister, Natalie-
dc.contributor.authorMonard, Simon-
dc.contributor.authorPeters, Justin-
dc.contributor.authorDundee, Phil-
dc.contributor.authorWilliams, Scott G-
dc.contributor.authorCostello, Anthony J-
dc.contributor.authorNeeson, Paul J-
dc.contributor.authorPal, Bhupinder-
dc.contributor.authorHuntington, Nicholas D-
dc.contributor.authorCorcoran, Niall M-
dc.contributor.authorPapenfuss, Anthony T-
dc.contributor.authorHovens, Christopher M-
dc.date2021-07-22-
dc.date.accessioned2021-10-25T22:33:59Z-
dc.date.available2021-10-25T22:33:59Z-
dc.date.issued2021-07-22-
dc.identifier.citationBMC Cancer 2021; 21(1): 846en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27807-
dc.description.abstractProstate cancer is caused by genomic aberrations in normal epithelial cells, however clinical translation of findings from analyses of cancer cells alone has been very limited. A deeper understanding of the tumour microenvironment is needed to identify the key drivers of disease progression and reveal novel therapeutic opportunities. In this study, the experimental enrichment of selected cell-types, the development of a Bayesian inference model for continuous differential transcript abundance, and multiplex immunohistochemistry permitted us to define the transcriptional landscape of the prostate cancer microenvironment along the disease progression axis. An important role of monocytes and macrophages in prostate cancer progression and disease recurrence was uncovered, supported by both transcriptional landscape findings and by differential tissue composition analyses. These findings were corroborated and validated by spatial analyses at the single-cell level using multiplex immunohistochemistry. This study advances our knowledge concerning the role of monocyte-derived recruitment in primary prostate cancer, and supports their key role in disease progression, patient survival and prostate microenvironment immune modulation.en
dc.language.isoeng
dc.subjectBayesen
dc.subjectCAPRA-Sen
dc.subjectCholesterolen
dc.subjectDeconvolutionen
dc.subjectDifferential gene expressionen
dc.subjectEpithelialen
dc.subjectFACSen
dc.subjectImmunohistochemistryen
dc.subjectMacrophagesen
dc.subjectMicroenvironmenten
dc.subjectMyeloiden
dc.subjectPDL1en
dc.subjectProstate canceren
dc.subjectTranscriptomicsen
dc.titleTranscriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.en
dc.typeJournal Articleen
dc.identifier.journaltitleBMC Canceren
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationUniversity of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, QLD, Australiaen
dc.identifier.affiliationThe Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australiaen
dc.identifier.affiliationFlow Cytometry Facility, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australiaen
dc.identifier.affiliationEpworth Center of Cancer Research, Clayton, Victoria, Australiaen
dc.identifier.affiliationCancer Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australiaen
dc.identifier.affiliationDepartment of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Urology, Frankston Hospital, Frankston, Victoria, Australiaen
dc.identifier.affiliationBioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medical Biology, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationPeter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australiaen
dc.identifier.affiliationSchool of Mathematics and Statistics, University of Melbourne, Melbourne, VIC, 3010, Australiaen
dc.identifier.affiliationInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republicen
dc.identifier.doi10.1186/s12885-021-08529-6en
dc.type.contentTexten
dc.identifier.orcid0000-0002-1102-8506en
dc.identifier.pubmedid34294073
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

32
checked on Jan 8, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.